Business

Cytokinetics Announces Recipients of Fourth Annual Communications Fellowship Grants

Total of $100,000 Awarded to Five Organizations to Support Communications and Community Outreach SOUTH SAN FRANCISCO, Calif., Jan. 24, 2022 (GLOBE NEWSWIRE)

articleCytokinetics, IncorporatedJanuary 24, 20224/company/cytokinetics-inc/news/cytokinetics-announces-recipients-of-fourth-annual-communications-fellowship-grants
Cytokinetics Announces Recipients of Fourth Annual Communications Fellowship Grants

About this update from Cytokinetics, Incorporated

[{"type":"text","content":"Total of $100,000 Awarded to Five Organizations to Support Communications and Community Outreach\nSOUTH SAN FRANCISCO, Calif., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the recipients of its fourth annual Communications Fellowship Grant program, intended to support increased capacity in communications, awareness building and community engagement for nonprofit organizations serving the patient community. Five grants in the amount of $20,000 each were awarded this year to patient advocacy organizations focused on heart failure, hypertrophic cardiomyopathy (HCM) and amyotrophic lateral sclerosis (ALS) communities. The grants will support projects to increase organizational reach, launch educational programs, grant patients access to pertinent conferences and reach underserved populations. “We are pleased to provide these five organizations with additional resources to help advance their initiatives and reach more patients in the communities they serve,” said Mary Pomerantz, Cytokinetics’ Director of Advocacy. “The recipients of our fourth annual Communications Fellowship Grant program each submitted creative, thoughtful and innovative proposals focused on making meaningful impacts for patients, caregivers and the community. We look forward to seeing how these grants may impact people living with heart failure, HCM and ALS.” The recipients of the 2022 Cytokinetics Communications Fellowship Grants are the following: Mended Hearts®: Mended Hearts is a cardiovascular peer-to-peer support organization with a mission of inspiring hope and helping to improve the quality of life of heart patients and their families through ongoing peer support, education, and advocacy. Mended Hearts will use this grant to launch a marketing plan with the goal of establishing its peer-to-peer services in an additional 20 locations over 2022. More specifically, the grant will be used to fund field volunteer training, simplified brochures for health care professionals, a professional commercial video and a digital strategy plan. Hypertrophic Cardiomyopathy Association: The Hypertrophic Cardiomyopathy Association (HCMA) is a non-profit organization that provides support, advocacy and education to patients, families, the medical community and the public about HCM while also supporting the research and developmen...

More updates from Cytokinetics, Incorporated